Search results
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The ...
Simply Wall St. via Yahoo Finance· 11 hours agoSince the market usually pay for a company’s long-term financial health, we decided to study the...
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO)
GuruFocus.com via Yahoo Finance· 3 hours agoThis recent transaction is part of a broader trend observed within the company, where there have...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 15 hours agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
Pharmaceutical Technology via Yahoo Finance· 16 hours agoIn May 2024 the company launched its sixth product in the US market. The company also reported net...
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 2 days agoA Different Perspective While the broader market gained around 25% in the last year, Rigel ...
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
Motley Fool via Yahoo Finance· 13 hours agoOne stock that is your typical high-risk, high-potential-reward option is Recursion Pharmaceuticals...
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 days agoWill the recent negative trend continue leading up to its next earnings release, or is Rocket ...
Collegium Pharmaceutical stock upgraded from Hold to Buy By Investing.com
Investing.com· 14 hours agoOn Friday, Collegium Pharmaceutical Inc. (NASDAQ:COLL) received an upgrade from Jefferies from Hold...
With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
Simply Wall St. via Yahoo Finance· 12 hours agoPharmaceuticals Insiders Aligned With All Shareholders? It's a necessity that company leaders act in...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 24 hours agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...